Vitestro Introduces First Autonomous Phlebotomist Robot In Europe
Dutch-based Vitestro will soon enter pivotal clinical trials with its blood-sampling device, which it hopes to market in 2024, pending regulatory approval.
Dutch-based Vitestro will soon enter pivotal clinical trials with its blood-sampling device, which it hopes to market in 2024, pending regulatory approval.